UNSPSC 51102857: Hydrocortisone/oxytetracycline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP350. This VA Drug Class (OP350) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51102857 Hydrocortisone/oxytetracycline is a Commodity code nominally describing a specific pharmaceutical combination, but recent state and local opportunities tagged under it show little alignment with that narrow scope. The code's recent activity captures a broad range of pharmaceutical and medical supply procurement: generic multi-source pharmaceuticals and OTC products distributed through state and local government facilities; naloxone and drug deactivation systems for community health support; medical and first aid supplies for fire-rescue operations; and exploratory direct-to-manufacturer prescription programs. Issuing bodies include state health and human services departments, county health systems, city fire departments, and multi-state cooperative purchasing alliances. The work spans routine consumables procurement (gloves, bandaging, oxygen delivery systems, endotracheal tubes), strategic pharmaceutical sourcing through wholesaler networks, and emerging pharmacy program innovation. Scope and issuing-body mix vary substantially across opportunities, suggesting the code captures pharmaceutical and medical supply activity more broadly than its commodity name implies.

Recent geographic activity centers on Florida, Texas, Minnesota, and Oregon. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, requiring vendors to supply through AmerisourceBergen, Cardinal Health, and Morris & Dickson with pricing effective July 1, 2026. Seminole County, Florida released an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The City of Tampa's Purchasing Department issued an ITB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies—including respiratory equipment, cardiac monitoring electrodes, and consumables—estimated at $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission posted an RFI (HHS0017013, due April 3, 2026) exploring vendor capabilities for direct-to-manufacturer prescription programs outside traditional PBM and GPO channels. The mismatch between the code's nominal pharmaceutical definition and the breadth of actual procurement activity suggests the code may capture pharmaceutical supply categories at a higher or inconsistent level of specificity within state and local taxonomies.